Yhn ScienceBiology first seen 6 d ago, last 8 min ago, peak #2
Novo Nordisk and Eli Lilly report GLP-1 signs of slowed biological aging
Original: Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD
Novo Nordisk and Eli Lilly presented findings at the Aging Research and Drug Discovery (ARDD) meeting suggesting GLP-1 drugs, best known for diabetes and weight loss, may show signals of slowed biological aging. The reports fuel debate over whether the blockbuster drugs could double as anti-aging therapies, extending their use beyond obesity and metabolic disease into longevity medicine.
Why now: GLP-1 drugs are already hugely popular, and the prospect they might slow aging dramatically expands their potential use.
Novo NordiskEli LillyARDDGLP-1 drugs
Rank over time, top of the chart is #1. 63 snapshots from 2 d ago to 8 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2933411